Detalhe da pesquisa
1.
Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
J Biol Chem
; 292(50): 20528-20543, 2017 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28972182
2.
Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
J Biol Chem
; 291(29): 15029-45, 2016 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27151212